Run-Long Medtech|Recently, the company announced that it will receive nearly 100
Date:2021-05-06 14:36:50 Click:
 
Beijing Run-Long Medtech CO.,LTD  recently announced the completion of a + round financing of nearly 100 million yuan, with Gelu capital continuously acting as the exclusive financial consultant. This round of financing is less than half a year away from the last round of financing. The current shareholder Xingze capital will make up for the investment, and the funds will be mainly used to promote product innovation and expand market investment.

Rylateco is an innovative medical device company focusing on the field of sports medicine and laying out the domestic high-end market. The company adheres to the corporate responsibility of "taking the needs of patients as the guidance and volunteering to become the doctor's partner", and is committed to building a leading brand of high-end medical devices and constantly breaking the international technology monopoly through product innovation, Strive to achieve leapfrog development in the "import substitution" opportunity period of sports medical device industry.

Spare no effort to catch up with the firm and indomitable medical industry in 2020. The company has been tough and catching up with the challenges in the face of adversity, turning challenges into opportunities, and promoting other industries with other excellent enterprises. It has promoted the sports medical industry in the field of Department of orthopedics, and maintained a sustained and rapid growth in the situation of the adverse situation. "The COVID-19" In the new year of Jinniu Spring Festival, with the promotion of a new round of investment, rylateco will usher in a higher starting point of development.

We have always adhered to the concept of professionalism and innovation, relying on the authoritative expert team, relying on professional management talents, building an advanced R & D system, integrating high-quality channel resources, and with the help of capital, increasing investment in product R & D and marketing, and achieved brilliant results! At the beginning of 2021, rylateco quickly obtained the registration certificates of four products, including "plasma RF blade". Up to now, it has held more than ten nmpa registration certificates, which further enriched the product system of rylateco. The acquisition of the registration certificate of plasma radiofrequency cutter head means that rilantake has completed the product layout in the two fields of planing cutter head and low-temperature plasma radiofrequency, and has fully covered the field of sports medicine cleaning surgery consumables. The products in this field account for 25% of the total market share of sports medicine consumables, which is the most common and the most demanding field in the field of sports medicine, but the domestic performance and quality can not meet the clinical needs. With the help of the market development of these two main products, rylateco has occupied a pivotal position in the field of sports medicine, established a high-end domestic brand image, and realized the rapid growth of market share.

Run-Long Medtech|Recently, the company announced that it will receive nearly 100 million yuan of follow-up investment from Xingze capital to speed up its growth strategy

With a sales team with rich industry experience and strong executive power, Ruilong Tyco has built a sales network covering more than 30 provinces and regions in China. Relying on the advantages of high-performance products, brand foundation and resources, Runlong Tyco has realized the rapid growth of sales performance. The average monthly sales in 2021 has reached three times of the level of the same period last year. In the future, we will make further use of the resources of industry, University and research, and make valuable local innovation. Combined with academic exchanges, basic education and training activities, we will push the new product of R & amp; R to the market, and let our products cover more needs and benefit people's livelihood.

For the success of this round of financing, Mr. Wang zhongran expressed his gratitude to the investor Xingze capital for its trust, and to the friends from all walks of life who have been paying attention to and supporting rylateco. Rylateco will take this as the driving force to continue to devote itself to the cause of sports medicine, provide high-quality products for doctors, and help patients overcome the pain.

As the exclusive investor in this round, Qiang Jing, partner of Xingze capital, said that ruilang Tyco is a perfect fit with Xingze's investment philosophy. It not only has the basic quality of an excellent medical technology enterprise, but also can undertake the social responsibility of serving doctors and patients and promoting the development of sports medicine. I believe that after this round of financing, ruilang Tyco will further improve its operation and management To consolidate the market and further enhance its influence and industry status, Xingze will continue to boost the common development of rylateco and sports medicine industry.

About Xingze capital

Xingze capital was established in 2015 under the name of "Xingze". It aims to integrate the resources of the big health industry through capital investment, promote the development of the industry, and benefit human beings. At present, the total assets under management of Xingze capital is nearly 4 billion yuan. The investment team is composed of more than 20 professionals and consultants with rich investment experience in the field of health care. Their professional backgrounds include life sciences, medicine, finance and law.

Xingze capital has always been committed to promoting the innovation and growth of Chinese enterprises and promoting the progress and development of social industries. With its rich industry experience, global resource network and excellent reputation in the industry, Xingze capital has spared no effort to help entrepreneurs realize their entrepreneurial dream.



  报错 笔记
 

Previous:Run-Long Medtech successfully appeared in Haikou IFOSMA with all our products

Copyright © 2020 北京瑞朗泰科医疗器械有限公司 All Rights Reserved 备:京ICP备8888888号-3

010-61507072

Sweep

Sweep